Shed membrane fragment-associated markers for endometrial and ovarian cancers

Gynecologic Oncology

Volumn 84, Issue 3, 2002, Pages 443-448

  Taylor, Douglas D ^a   Lyons, Karen S ^a   Gerçel Taylor, Çiçek ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS LIGAND; GELATINASE A; GELATINASE B; MEMBRANE PROTEIN; PROTEINASE; TUMOR PROTEIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CELL; CANCER DIAGNOSIS; CANCER GROWTH; CANCER STAGING; CELL MEMBRANE; CHROMATOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM CANCER; ENZYME ACTIVITY; FEMALE; HUMAN; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 0036197006     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6551     Document Type: Article

References (30)

1. Epidemiology of ovarian cancer
2. Ovarian cancer biology
3. Ovarian cancer screening
4. Ovarian cancer screening in the general population
5. Ovarian cancer screening
6. Sonographic endometrial thickness: A useful test to predict atrophy in patients with postmenopausal bleeding. An Italian multicenter study
7. Shedding of plasma membrane fragments: Neoplastic and developmental importance
8. Neoplastic and developmental importance of plasma membrane vesicles
9. Shed membrane vesicles: A mechanism for tumor induced immunosuppression
10. Membrane vesicles in ovarian cancer fluids: A new potential marker
11. Matrix-degrading proteinases are shed by ovarian cancer in vivo and in vitro
12. CD95 ligand expression as a mechanism of immune escape in breast cancer
13. Nomenclature and glossary of the matrix metalloproteinases
14. Biology and biochemistry of proteinases in tumor invasion
15. Amount and proteolytic content of vesicles shed by cancer cell lines correlate with their in vitro invasiveness
16. Circulating soluble Fas ligand in patients with gastric carcinoma
17. Expression of the Fas ligand in cells of T cell lineage
18. Fas-mediated cytotoxicity by freshly isolated natural killer cells
19. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and co-expression in adult tissues characterized by apoptotic cell turnover
20. Fas ligand-induced apoptosis as a mechanism of immune privilege
21. A role for CD95 ligand in preventing graft rejection
22. Expression of Fas ligand by human cytotrophoblasts: Implication for placentation and fetal survival
23. Isolation of plasma membrane fragments from cultured murine melanoma cells
24. Enzyme-linked coagulation assay. IV. Sensitive sandwich enzyme-linked immunosorbent assays using Russell's viper venom factor X-activator-antibody conjugates
25. Sensitive assay for measurement of antibodies to Clostridium botulinum neurotoxins A, B and E: Use of hapten-labeled-antibody elution to isolate specific complexes
26. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
27. Increased accumulation of p53 protein in cisplatin-resistant ovarian cell lines
28. Lysophosphatidic acid promotes matrix metalloproteinases (MMP) activation and MMP-dependent invasion in ovarian cancer cells
29. Characterization of plasma membrane shedding from murine melanoma cells